# US 2010/0167267 A1 · Mass Spectrometric Quantitation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167267 A1
- Document ID: US20100167267A1
- Status: Published application
- Kind: A1
- Application number: 12/530,747
- Filed: 2008-03-12
- Published: 2010-07-01
- Earliest claimed: 2007-03-12
- Assignees: Electrophoretics Limited
- Inventors: Peter Schulzknappe; Ian Pike; Karsten Kuhn
- Web page: https://patentgrep.com/patent/US20100167267A1

## CPC

- G01N 33/58: involving labelled substances (G01N33/53 takes precedence)
- G01N 1/28: Preparing specimens for investigation {including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q}(mounting specimens on microscopic slides G02B21/34; means for supporting the objects or the materials to be analysed in electron microscopes H01J37/20 {; laboratory gas handling apparatus B01L5/00})
- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- G01N 33/6851: {Methods of protein analysis involving laser desorption ionisation mass spectrometry}
- G01N 33/96: involving blood or serum control standard
- H01J 49/0009: {Calibration of the apparatus}
- G01N 2001/2893: {Preparing calibration standards}
- G01N 2333/4703: Regulators; Modulating activity
- G01N 2333/765: Serum albumin, e.g. HSA
- G01N 2333/775: Apolipopeptides
- G01N 2458/15: Non-radioactive isotope labels, e.g. for detection by mass spectrometry
- G01N 2560/00: Chemical aspects of mass spectrometric analysis of biological material
- G01N 2570/00: Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
- Y10T 436/105831: Protein or peptide standard or control [e.g., hemoglobin, etc.]
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- H01J: ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS (spark-gaps H01T; electric arc lamps H05B31/00; particle accelerators H05H)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

Provided is a method of assaying for an analyte, which method comprises: a) combining a test sample, which may comprise the analyte, with a calibration sample comprising at least two different aliquots of the analyte, each aliquot having a known quantity of the analyte, wherein the sample and each aliquot are differentially labeled with one or more isobaric mass labels each with a mass spectrometrically distinct mass marker group, such that the test sample and each aliquot of the calibration sample can be distinguished by mass spectrometry; b) determining by mass spectrometry the quantity of the analyte in the test sample and the quantity of the analyte in each aliquot in the calibration sample, and calibrating the quantity of the analyte in the test sample against the known and determined quantities of the analytes in the aliquots in the calibration sample.

## Claims

### Claim 1

A method of assaying for an analyte, which method comprises:
a) combining a test sample, which may comprise the analyte, with a calibration sample comprising at least two different aliquots of the analyte, each aliquot having a known quantity of the analyte, wherein the sample and each aliquot are differentially labelled with one or more isobaric mass labels each with a mass spectrometrically distinct mass marker group, such that the test sample and each aliquot of the calibration sample can be distinguished by mass spectrometry;
b) determining by mass spectrometry the quantity of the analyte in the test sample and the quantity of analyte in each aliquot in the calibration sample, and calibrating the quantity of the analyte in the test sample against the known and determined quantities of the analytes in the aliquots in the calibration sample.

### Claim 2 (depends on 1)

A method according to claim 1, wherein the test sample may comprise a plurality of different analytes and a calibration sample is provided for each different analyte, and wherein step (b) is repeated for each different analyte.

### Claim 3 (depends on 2)

A method according to claim 2, wherein the plurality of analytes are peptide fragments of a protein or polypeptide which are produced by chemical or enzymatic processing of the protein or polypeptide prior to step (a).

### Claim 4 (depends on 2)

A method according to claim 2, wherein the different aliquots of each calibration sample are selected such that each calibration sample provides a range of quantities of analyte which are different to the range of quantities of analyte in other calibration samples.

### Claim 5 (depends on 1)

A method according claim 1, wherein a plurality of test samples are assayed for an analyte.

### Claim 6 (depends on 5)

A method according to claim 5, wherein each of the plurality of test samples is assayed for the same analyte.

### Claim 7 (depends on 6)

A method according to claim 6, wherein each of the test samples is differentially labelled with one or more of the isobaric mass labels and combined with a single calibration sample in step (a), and the quantity of the analyte in each sample is determined simultaneously in step (b).

### Claim 8 (depends on 6)

A method according to claim 6, wherein each test sample is labelled with the same mass label, and steps (a) and (b) are repeated for each different sample.

### Claim 9 (depends on 8)

A method according to claim 8, wherein the same calibration sample is used for each test sample to be assayed.

### Claim 10 (depends on 1)

A method according claim 1, wherein the method comprises a further step prior to step (a) of differentially labelling each test sample or each aliquot of the calibration sample with one or more isobaric mass labels.

### Claim 11 (depends on 10)

A method according to claim 10, which comprises a further step of combining the differentially labelled aliquots to produce a calibration sample prior to step (a).

### Claim 12 (depends on 1)

A method according to claim 1, wherein step (b) comprises:
i) in a mass spectrometer selecting and fragmenting ions of a mass to charge ratio corresponding to the analyte labelled with the mass label, detecting and producing a mass spectrum of fragment ions, and identifying the fragment ions corresponding to the mass marker groups of the mass labels;
ii) determining the quantity of the analyte in each test sample on the basis of the quantity of their mass marker groups in a mass spectrum relative to the quantities of the mass marker groups from the aliquots of the calibration sample in the same mass spectrum.

### Claim 13 (depends on 1)

A method according to claim 1, wherein the quantity of an analyte in each aliquot in the calibration sample is a known absolute quantity.

### Claim 14 (depends on 13)

A method according to claim 13, wherein the absolute quantity of an analyte in a test sample is determined in step (b).

### Claim 15 (depends on 1)

A method according to claim 1, wherein the quantity of analyte in each aliquot in the calibration sample is a known qualitative quantity.

### Claim 16 (depends on 15)

A method according to claim 15, wherein the qualitative quantity is an expected range of quantities of analyte in a subject having a particular state.

### Claim 17 (depends on 15)

A method according to claim 15, wherein the calibrating step comprises calibrating the quantity of the analyte in the test sample against the known qualitative and determined quantities of the analytes in the aliquots of the calibration sample.

### Claim 18 (depends on 17)

A method according to claim 17, wherein the percentage change in the amount of the analyte in the test sample is determined.

### Claim 19 (depends on 1)

A method according to claim 1, wherein the quantity of analyte in each different aliquot is selected to reflect the known or suspected variation in the quantity of the analyte in the test sample.

### Claim 20 (depends on 19)

A method according to claim 19, wherein aliquots are provided which comprise the analyte in quantities which correspond to the upper and lower limits, and optionally intermediate points within a range of the known or suspected quantities of the analyte found in test samples of healthy or diseased subjects.

### Claim 21 (depends on 1)

A method according to claim 1, wherein the different quantities of analyte present in the different aliquots correspond to the known or suspected quantity of analyte present in a test sample which has been incubated for different periods of time.

### Claim 22 (depends on 1)

A method according to claim 1, wherein the aliquots are taken from a sample which is a standardised form of the test sample.

### Claim 23 (depends on 1)

A method according to claim 1, wherein the test sample and/or the aliquots of the calibration sample are from a plant or an animal.

### Claim 24 (depends on 23)

A method according to claim 23, wherein the animal is a human.

### Claim 25 (depends on 1)

A method according to claim 1, wherein the calibration sample comprises an analyte in a quantity that indicates the efficacy and/or toxicity of a therapy.

### Claim 26 (depends on 1)

A method according to claim 1, wherein the test sample and/or the calibration sample comprises human or animal tissue, blood, plasma, serum, cerebrospinal fluid, synovial fluid, ocular fluid, urine, tears, tear duct exudates, lung aspirates, breast milk, nipple aspirate, semen, lavage fluid, cell extract, tissue culture extract, plant tissue, plant fluid, plant cell culture extract, a bacterial sample, a virus sample, fungus, fermentation broth, a foodstuff or a pharmaceutical composition.

### Claim 27 (depends on 1)

A method according to claim 1, wherein the analyte comprises a protein, a polypeptide, a peptide, an amino acid or a nucleic acid, a peptide-nucleic acid, a sugar, starch, a complex carbohydrate, a lipid, a polymer, or fragments thereof.

### Claim 28 (depends on 1)

A method according to claim 1, which further includes the step of separating the isobarically labelled analytes electrophoretically or chromatographically after step (a) but before step (b).

### Claim 29 (depends on 1)

A method according to claim 1, wherein the calibration sample comprises a further aliquot which comprises the analyte in a quantity which serves as a trigger during an MS scan or during non-scanning MS/MS to initiate an MS/MS scan.

### Claim 30 (depends on 29)

A method according to claim 29, wherein the analyte in the further aliquot is labelled with an isobaric mass label.

### Claim 31 (depends on 29)

A method according to claim 29, wherein the analyte in the further aliquot is labelled with a mass label which is chemically identical to but isotopically distinct and differing in mass from the isobaric mass labels of the other analytes in the calibration sample

### Claim 32 (depends on 1)

A method according to claim 1, wherein the analyte in the sample is a protein, and the analyte in the calibration sample is a recombinant form of the protein in the sample.

### Claim 33 (depends on 1)

A method according to claim 1, wherein the mass label comprises the following structure:
X-L-M
wherein X is a mass marker moiety comprising the following group:
wherein the cyclic unit is aromatic or aliphatic and comprises from 0-3 double bonds independently between any two adjacent atoms; each Z is independently N, N(R1), C(R1), CO, CO(R1), C(R1)2, O or S; X is N, C or C(R1); each R1 is independently H, a substituted or unsubstituted straight or branched C1-C6 alkyl group, a substituted or unsubstituted aliphatic cyclic group, a substituted or unsubstituted aromatic group or a substituted or unsubstituted heterocyclic group; and y is an integer from 0-10, L is a cleavable linker and M is a mass normalisation moiety.

### Claim 34 (depends on 33)

A method according to claim 33, wherein the cleavable linker attaching the mass marker moiety to the mass normalisation moiety is a linker cleavable by collision.

### Claim 35 (depends on 34)

A method according to claim 34, wherein the linker is cleavable by CID, ETD, ECD or SID using mass spectrometry.

### Claim 36 (depends on 10)

A method according to claim 10, wherein the labelling step comprises a step of reacting the analyte with a reactive mass label, wherein the reactive mass label comprises a mass label and a reactive functionality.

### Claim 37 (depends on 36)

A method according to claim 36, wherein the reactive functionality is capable of reacting with any amino group on a polypeptide and comprises a nucleophile or an electrophile.

### Claim 38 (depends on 36)

A method according to claim 36, wherein the reactive functionality comprises the following group:
wherein each R2 is independently H, a substituted or unsubstituted straight or branched C1-C6 alkyl group, a substituted or unsubstituted aliphatic cyclic group, a substituted or unsubstituted aromatic group or a substituted or unsubstituted heterocyclic group.

### Claim 39 (depends on 33)

A method according to claim 33, wherein the mass label is a mass label from a set of two or more mass labels,
wherein each mass normalisation moiety ensures that a mass label has a desired aggregate mass, and wherein the set comprises:
mass labels having a mass marker moiety, each mass marker moiety having a mass different from that of all other mass marker moieties in the set, and each label in the set having a common aggregate mass.
and wherein all the mass labels in the set are distinguishable from each other by mass spectroscopy.

### Claim 40 (depends on 39)

A method according to claim 39, wherein each mass label in the set has a mass adjuster moiety, selected from:
(a) an isotopic substituent situated within the mass marker moiety and/or within the mass normalisation moiety, and
(b) substituent atoms or groups attached to the mass marker moiety and/or attached to the mass normalisation moiety.

### Claim 41 (depends on 40)

A method according to claim 40, wherein the mass adjuster moiety is selected from a halogen atom substituent, a methyl group substituent, and 2H, 15N, 13C or 18O isotopic substituents.

### Claim 42 (depends on 41)

A method according to claim 41, wherein the mass adjuster moiety is 15N or 13C and the set comprises two mass labels having the following structures:

### Claim 43 (depends on 41)

A method according to claim 41, wherein the mass adjuster moiety is 15N and 13C and the set comprises five mass labels having the following structures:

### Claim 44 (depends on 41)

A method according to claim 41, wherein the mass adjuster moiety is 15N and 13C and the set comprises six mass labels having the following structures:

### Claim 45 (depends on 33)

A calibration sample for use in a mass spectrometric assay for an analyte which comprises at least two different aliquots of the analyte, wherein each aliquot is differentially labelled with an isobaric mass label as defined in claim 33.

### Claim 46

A method of assaying for an analyte, which method comprises:
a) optionally preparing an isobarically labelled reference material containing a reference biomolecule or mixture of reference biomolecules by reacting with a set of mass labels, each mass label with a mass spectrometrically distinct reporter group;
b) labelling a sample in which the quantity of the biomolecule or mixture of biomolecules is to be quantified by reacting with one of the same set of mass labels as used in step a);
c) adding a known amount of the isobarically labelled reference material into the isobarically labelled test sample prepared in step b);
d) optionally separating the isobarically labelled biomolecules electrophoretically or chromatographically;
e) ionising the labelled biomolecules in a mass spectrometer;
f) selecting ions of a predetermined mass to charge ratio corresponding to the mass to charge ratio of the preferred ions of the labelled biomolecule in a mass analyser;
g) inducing dissociation of these selected ions by collision or electron transfer;
h) detecting the collision products to identify collision product ions that are indicative of the mass labels;
i) producing a standard curve of ion intensity versus biomolecule amount based on intensity of the collision product ions that are indicative of the mass labels;
j) calculating the absolute or relative abundance of the biomolecule or mixture of biomolecules.
